Stay updated on Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added 'Type 2 diabetes' as a related topic and linked 'MedlinePlus Genetics' as a related topic on the study page.
    Difference
    0.2%
    Check dated 2025-12-31T00:30:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.3.3) and removal of several footer links, including HHS Vulnerability Disclosure and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-23T21:57:19.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Added Type 2 Diabetes as the condition and MedlinePlus Genetics as a related topic on the study page. This strengthens the clinical context and provides an additional reference for readers.
    Difference
    0.2%
    Check dated 2025-12-09T18:59:36.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2025-11-25T10:52:04.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The changes remove a government funding notice banner and a few related-topic links (Type 2 diabetes and MedlinePlus Genetics) from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T06:58:51.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The page now lists 'Type 2 diabetes' as a condition keyword and adds 'MedlinePlus Genetics' as a related topic; these are minor metadata/content updates that do not alter the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-03T20:58:34.000Z thumbnail image

Stay in the know with updates to Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.